Verve Therapeutics(NASDAQ:VERV) 
Verve Therapeutics, Inc, a clinical stage genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases in the United States.
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-01-27
P
O 7.86
H 8.05
L 7.61
C 7.76
V 1,267,180
10EMA 7.76
20EMA 7.76
60EMA 7.76
120EMA 7.76
250EMA 7.76